News
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
1d
TipRanks on MSNGSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer Treatment
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...
U.S. District Judge Paul Diamond, of the Eastern District of Pennsylvania, said he was considering sanctions against Steve ...
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...
Haleon (erstwhile GlaxoSmithKline Consumer Healthcare) and the Indian Dental Association (IDA) successfully partnered to ...
Over 100 employees from GSK’s Hamilton site recently rolled up their sleeves for their annual "Together Days," a volunteer ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
9d
TipRanks on MSNGlaxoSmithKline Reports Strong Q2 2025 Performance
GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
GlaxoSmithKline ‘s spinoff of its consumer health business will allow the remaining company to grow sales by more than 5% a year for the next half-decade, but at the near-term cost of a hefty ...
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results